---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089549"
form_type: "8-K"
ticker: "TRDA"
cik: "0001689375"
company_name: "Entrada Therapeutics, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:14:36.017442+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Entrada Therapeutics appoints Gina Chapman to board effective Sept 1, 2023

## Summary
- Gina Chapman, President and CEO of CARGO Therapeutics, joins as Class III director.
- Effective Sept 1, 2023; also appointed to Nominating and Corporate Governance Committee.
- Initial equity grant of $500K value (32,000 shares of common stock) vesting over 3 years.
- Annual director fee of $40,000 plus $4,000 for committee service; standard indemnification.

## SEC filing metadata
- accession: 0001104659-23-089549
- form_type: 8-K
- ticker: TRDA
- cik: 0001689375
- company_name: Entrada Therapeutics, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/0001104659-23-089549-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/tm2323293d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089549
- JSON: https://secwatch.observer/filing/0001104659-23-089549.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089549.txt

## Key facts
- Executive change
  Gina Chapman was appointed as Class III director at Entrada Therapeutics, Inc..
  - Action: appointed
  - Role: Class III director
  source text: On August 4, 2023, the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”) appointed Gina Chapman to the Board as a Class III director, effective September 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689375/000110465923089549/0001104659-23-089549-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.